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Abstract
Background: Hypertension remains the major risk factor for cardiovascular diseases (CVDs) worldwide with a preva‑
lence and mortality in low- and middle-income countries (LMICs) among the highest. The early detection of hyper‑
tension risk factors is a crucial pillar for CVD prevention.
Design and method: This cross-sectional study included 4284 subjects, mean age 46 ± 16SD, 56.4% females and
mean BMI 26.6 ± 3.7 SD. Data were collected through a screening campaign in rural area of Kirehe District, Eastern of
Rwanda, with the objective to characterize and examine the prevalence of elevated blood pressure (BP) and other
CVD risk factors. An adapted tool from the World Health Organization STEPwise Approach was used for data collec‑
tion. Elevated BP was defined as ≥ 140/90 mm/Hg and elevated blood glucose as blood glucose ≥ 100 mg/dL after a
6-h fast.
Results: Of the sampled population, 21.2% (n = 910) had an elevated BP at screening; BP was elevated among indi‑
viduals not previously known to have HTN in 18.7% (n = 752). Among individuals with a prior diagnosis of HTN, 62.2%
(n = 158 of 254) BP was uncontrolled. Age, weight, smoking, alcohol history and waist circumference were associated
with BP in both univariate analyses and multivariate analysis.
Conclusion: High rates of elevated BP identified through a health screening campaign in this Rwandan district were
surprising given the rural characteristics of the district and relatively low population age. These data highlight the
need to implement an adequate strategy for the prevention, diagnosis, and control of HTN that includes rural areas of
Rwanda as part of a multicomponent strategy for CVD prevention.
Keywords: High blood pressure, Hypertension, Screening, Rwanda
Background
Cardiovascular diseases (CVDs) are the leading cause of
morbidity and mortality worldwide [1, 2] and approximately 80% of all cardiovascular deaths occur in low- and
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middle-income countries [1, 3]. By 2030, cardiovascular
deaths are projected to increase to 23 million globally [4]
and double in Sub-Saharan Africa (SSA) from 1 million
deaths in 2013 [5].
Hypertension (HTN) is the most prevalent risk factor
for CVD mortality worldwide [3]. Although hypertension is a well-document public health threat in developing countries, population-based data on HTN prevalence
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is scarce from SSA. Based on one report, the estimated
prevalence of HTN in SSA is 16.2%, ranging from 10.6%
in Ethiopia to 29.6% in Ghana. In SSA, the prevalence of
HTN is also higher in urban (20.7%) compared with rural
(13.7%) areas [6], a difference generally attributed to lifestyle changes commonly associated increasing urbanization (physical inactivity, obesity, smoking, and alcohol
consumption) [7]. Similar to other LMICs, Rwanda is
experiencing epidemiological transition in urban areas
with changes in lifestyle behaviors which portends
increased healthcare burden, morbidity, and mortality
from CVDs.
Early detection and management remain a key costeffective strategy for the prevention of chronic CVDs [6,
8, 9]. However, there is a lack of data on the prevalence
of CVD risk factors among adults living in remote rural
areas which are less geographically accessible. This fundamental data gap hampers efforts to characterize the
CVD risk profile in mainly rural regions, further impeding efforts to establish appropriate preventive measures targeting these underserved populations [1, 10]. To
bridge this gap, this study aimed to measure the rates of
and risk factors for HTN in people living in a rural area
of Rwanda through a screening campaign the Kirehe District, an eastern province of Rwanda.

Methods
Study design and procedures

This was a cross-sectional study that included adult
(≥ 18 years) Rwandan people who participated in campaign on voluntary basis for five days from 23rd to 29th
September, 2018. The study design followed the other
reported screening studies design [11]. In addition, it has
integrated elements from Health Beliefs Model (HBM)
[12] to explore the rates and predictors of HTN in the
community. The screening was conducted by trained
volunteers (medical students and nurses) from health
centers (HCs) in the Kirehe district hospital catchment
area. The core role of the Kirehe district leadership was
to arrange with local authorities to sensitize and invite
people for screening by using local and public communications and radio publicity spots. The screening site was
designed by HCs leadership and staff of Rwanda Biomedical Centre (RBC), a government institution under the
Ministry of Health responsible for implementing health
polices and health services in the community.
Study setting

The study was conducted in 8 sectors in the Kirehe District that were systematically selected. The Kirehe District, one of the rural area districts situated in Eastern
province of Rwanda bordering Tanzania, covers a total
area of 1118.5 Km2 with a population of 340,983 (52%
female) according to National Institute of Statistics of
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Rwanda (NISR). Ninety percent (90%) of the economic
activity in the district depends on agriculture and livestock [13].
Data collection

Data collection was done after verbal consent of participants by using an adapted World Health Organization
STEPwise Approach to NCD Risk Factor Surveillance
tool [14]. Data collected included demographics, social
history of alcohol intake and smoking, prior history of
hypertension, and time since last meal. Measurements
included anthropometrics, blood pressure and blood glucose. After a resting in a seated position for 5 min, blood
pressure (BP) was taken three times separated by 1 min
following a standardized protocol with a calibrated and
automated BP machine (Omron M2, Kyoto, Japan). The
mean of the 2nd and 3rd readings was recorded. Waist
circumference (WC) was measured in triplicate at the
level of the midpoint between the lower margin of the
last palpable rib and the top of the iliac crest after expiration using a 203 cm Seca® measuring tape (all Seca
GmbH & Co. KG., Hamburg, Germany); the mean of the
three WC measures was used for analysis [15]. Weight
was measured using a digital S
 eca® 813 scale and height
®
using a Seca 213 stadiometer. As the BP measures were
taken casually and do not necessarily reflect a well-established hypertension diagnosis [16], we used the term
of “Elevated BP” to reflect a systolic BP greater than or
equal to 140 mmHg and/or a diastolic BP greater than
or equal to 90 mmHg [17, 18]. This definition of elevated
BP has nothing do with the definition of hypertension
staging, used in some guidelines [16]. Data on the use of
anti-hypertensive medications was not collected; a separate question surveyed whether the subject had ever been
diagnosed with HTN.
A screening blood glucose (BG) was measured using
a portable-battery driven Accu-Check® Aviva (Roche
Diagnostics GmbH, Mannheim, Germany); the number
of fasting hours as recorded and categorized form 0–6 h
and 6 h and above (6 h corresponding to the night period
from midnight to 6.00 a.m. where no food intake is usually expected). This was decided after the pilot where we
found most of participant not remembering the exact
time of their last food intake (not only food or meal but
also including all kinds of mouth intake, a common situation in rural families).
As the BG measures were taken casually and do not
necessarily reflect a well-established diabetes diagnosis
[19], we used the term “elevated blood glucose” to reflect
glycaemia greater than or equal to 100 mg/dL [19–21].
Participants who had elevated BP or self-reported use
of HTN medications or had elevated BG were referred
to the nearest health center for regular follow-up. Those
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individuals with normal BP were counselled on NCD risk
reduction for primary prevention. The blood glucose and
blood pressure results were communicated to participants immediately. The study was conducted in accordance with the principles of the Declaration of Helsinki
and local Rwandan regulations.

We inspect the correlations between the predictors,
using a correlation map to assess the collinearity, and
highly correlated variables were entered one by one to
test the best model. All variables in bivariate analyses
with p value < 0.05 were considered for inclusion in multivariate regression model.

Statistical methods and data analysis

Results

Data was captured by a study team person using spreadsheet software program (Microsoft Excel, Microsoft Corporation, 2018), then de-identified and transferred to
STATA 15.5 Version (Stata Corporation, College Station,
TX) for analysis. Data are presented as mean ± standard
deviation (SD) or percentage (number). Comparisons
were performed by unpaired t-tests, one-way ANOVA
and χ2-test as appropriate. Results with p values < 0.05
were considered statistically significant. Univariate and
multivariate regression analyses were used to assess relationships between different risk factors and the presence
of elevated BP in the total population and in subgroups
defined by the absence or presence of a prior diagnosis
of HTN.

Participant characteristics by blood pressure category

A total of 4284 participants in Kirehe district completed
a 5-day screening program as part of routine monthly
physical activity national program. The participants were
largely middle-aged (mean age: 46 ± 16 years, range:
18–98 years), female (56, 4%), mildly overweight, and
the majority had a history of alcohol intake (Table 1).
Females were younger than males (mean age: 45 ± 16 vs.
47 ± 16 years; p < 0.001). More than one-third of participants (34%) reported history of smoking; 14.8% (n = 636)
were current smokers and 19.2% (n = 821) were former
smokers.
Of the 4284 individuals in the sampled cohort, 21.2%
(n = 910) had elevated BP. Also 158 of 910 (17.4%) with
elevated BP had a prior diagnosis of HTN and represent

Table 1 Participants’ characteristics and elevated blood pressure (BP) outcome
Participant
characteristics

Total
screened
population
N = 4284

Comparisons by elevated blood pressurea
Normal BP
n = 3374

All elevated BP
n = 910 (21.2%)
Mean ± SD or %
(n)

Elevated BP in known
hypertensive subjects
n = 158 (62.2%) of 254

p valueb Mean ± SD or %
(n)

Female (%) (n)

56.4 (2417)

57.0 (1922)

54.4 (495)

Age (years)

46 ± 16

44 ± 15

55 ± 15

< 0.001

73.6 ± 9.3

72.8 ± 8.2

76.7 ± 12

< 0.001

Height (cm)
Weight (kg)
BMI (kg/m2)

166 ± 4

166 ± 4

166 ± 4

0.165
0.486

26.6 ± 3.7

26.4 ± 3.3

27.7 ± 4.6

< 0.001

80.4 ± 18.6

< 0.001

Smoking history
(%) (n)

34.0 (1457)

26.6 (896)

61.6 (561)

Alcohol history
(%) (n)

63.8 (2732)

58.1 (1959)

Systolic BP (mmHg)

127 ± 18

Blood glucose (mg/
dL)

101 ± 22

Elevated blood
glucose (%) (n)c

18.2 (779)

Waist circumference 74.4 ± 16.6
(cm)

Diastolic BP (mmHg) 76 ± 11

54.4 (86)

Elevated BP in non-known
hypertensive subjects
n = 752 (18.7%) of 4030

p valueb Mean ± SD or %
(n)
0.530

56 ± 14

< 0.001

76.2 ± 12.1

< 0.001

166 ± 4

0.193

27.8 ± 4.7

< 0.001

80.0 ± 18.2

< 0.001

< 0.001

61.4 (97)

84.9 (773)

< 0.001

119 ± 12

153 ± 14

< 0.001

100 ± 21

72.7 ± 15.6

72 ± 8

16.5 (558)

88 ± 9

< 0.001

105 ± 25

< 0.001

24.3 (221)

< 0.001

54.4 (409)

p valueb
0.197

55 ± 15

< 0.001

76.7 ± 12

< 0.001

166 ± 4

0.180

27.7 ± 4.7

< 0.001

80.5 ± 18.6

< 0.001

< 0.001

61.7 (464)

< 0.001

82.9 (131)

< 0.001

85.4 (642)

< 0.001

153 ± 16

< 0.001

153 ± 13

< 0.001

103 ± 30

0.051

7.6 (12)

0.003

89 ± 9

< 0.001

88 ± 9

< 0.001

105 ± 24

< 0.001

27.8 (208)

< 0.001

Table combine both descriptive data on the total screened population (first column) and univariate participants characteristics comparison between each time the
normal BP group versus elevated BP, versus poorly controlled BP and versus new discovered cases BP groups
a
b
c

Elevated blood pressure was defined as a systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg
Comparison by unpaired t-test or χ2, Normal BP as comparison group of all p values

Elevated blood glucose ≥ 100 mg/dL after minimum 6-h fast
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62.2% of all individuals with a prior diagnosis of HTN
(158/254). 752 of 910 (82.6%) individuals detected with
elevated BP were without a prior diagnosis of HTN and
represent 18.7% of all participants without history of
HTN. A separate analysis which included known cases
with controlled hypertension showed a normal BP with
mean systolic blood pressure (SBP) of 127 ± 19 mmHg,
and mean diastolic pressure (DBP) of 77 ± 11 mmHg
(Additional file 1). The proportion of new discovery of
elevated BP progressively increased with advancing age:
19.1% in 45–54 year old, 27.2% in 55–64 year old, and
33.4% among those with age > 65 years (Fig. 1).
Gender was similar between Normal BP and Elevated
BP categories (Table 1). Age, weight, body mass index
(BMI), and waist circumference were all higher in the
Elevated BP categories compared with the Normal BP (all
p < 0.001). Fasting blood glucose concentration was significantly higher in the all elevated BP and Elevated BP
among Non-Known Hypertensive subjects. The prevalence of smoking history, alcohol consumption, and
elevated blood glucose are all higher in the Elevated BP
categories compared with the Normal BP category (all
p < 0.005).
The distribution of BP category was similar across BMI
categories (Fig. 2). An elevated BG was found in 18.2%
(n = 779) of participants, with a greater proportion of
elevated BP among those participants with BG ≥ 100 mg/
dL (Fig. 3). Among the 713 participants (16.6%) with
a reported diagnosis of diabetes, 616 (79.1%) had a
BG ≥ 100 mg/dL; BG was elevated in 163 participants

without a reported diagnosis of diabetes (3.8% of the total
screened population, 4.6% among participants without a
reported diagnosis of diabetes) (Additional file 1).
Independent risk factors of elevated BP in the 3 groups:
general screened population, known hypertensive
population and the newly discovered elevated BP
sub‑groups

Table 2 presents a multivariate analysis results of risk
factors in the Normal BP group versus each of the three
Elevated BP categories: All Elevated BP, Elevated BP in
Known Hypertensive subjects, and Elevated BP in NonKnown Hypertensive subjects. The findings revealed that
advanced age was independently associated with progressively increased risk of having elevated BP in all three
comparisons (all p < 0.001). The relationship between Elevated BP category with overweight (25 ≤ BMI < 30 kg/m2)
and obesity (BMI ≥ 30 kg/m2), weight, waist circumference, and fasting blood glucose were less consistent. Current smoking, alcohol consumption, and fasting blood
glucose are significant predictors of Elevated BP in multivariate models (Table 2).

Discussion
This report revealed two main unexpected findings: A
high rate of Elevated BP among individuals not known
to have hypertension (18.7%), a higher rate of elevated
BP in individuals with a known diagnosis of hypertension (62.2%), and high rates of elevated blood glucose
(79.1%). High rates of elevated BP and elevated BG
identified through a health screening campaign in this

Number of participants according to age group and Blood Pressure

Number of participants

2500

2000

2.9%
8.9 %

1500

1000

88.2%
5.4%
19.1%

500
75.4%

0

18-44

45-54

10.3%
27.2%
62.5%

55-64

11.6%
33.4%
55.0%

>65

Age group (years)
Normal BP

Elevated BP (New Cases)

Fig. 1 Number of participants according to age group and blood pressure

Elevated BP (Known cases)

Ntaganda et al. BMC Cardiovascular Disorders

Proportion (percentage) of participants

100%
90%
80%

(2022) 22:197

Page 5 of 10

4.6

6.0

6.3

17.1

18.9

76.9

74.7

<25

25≤BMI<30

15.6

70%
60%
50%
40%

79.8

30%
20%
10%
0%

Body Mass Index
Normal BP

Elevated BP (New Cases)

≥30

(kg/m2)

Elevated BP (Known cases)

Fig. 2 Number of participants by BMI and BP class

Number of participants according to Blood glucose level and BP
4500

Number of participants

4000
3500

5.1 %
12.7%

3000
2500
2000
1500

82.1%

1000

3.4%
20.4%

500

76.1%

0

Blood glucose < 100 mg/dl

Blood glucose ≥ 100 mg/dl

Blood glucose level
Normal BP

Elevated BP (New Cases)

Elevated BP (Known cases)

Fig. 3 Number of participants according to blood glucose level and BP

Rwandan district were surprising given the rural characteristics of the district and relatively low population
age (46.4 ± 15.8 years).

Awareness and hypertension control in this study

This report identified a high prevalence of elevated BP
in individuals not previously known to have hypertension. This finding confirms both a high prevalence and
a poor awareness of HTN typical of [17] especially in
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Table 2 Participants characteristics associated elevated BP in multivariate analysis
Normal BP versus all elevated BPa

Normal BP versus elevated BP in
known hypertensive subjects

Normal BP versus elevated BP
in non-known hypertensive
subjects

OR (95%CI)

OR (95% CI)

OR (95% CI)

p value

p value

p value

Age (years)
18–44

Refd

45–54

1.8X [1.46–2.36]

< 0.001*

1.87 [1.10–3.18]

0.021*

1.76 [1.35–2.88]

< 0.001*

55–64

3.05 [2.41–3.85]

< 0.001*

3.81 [2.35–6.19]

< 0.001*

2.81 [2.17–3.63]

< 0.001*

3.91 [3.03–5.03]

< 0.001*

4.43 [2.62–7.49]

< 0.001*

3.63 [2.75–4.78]

< 0.001*

1.02 [1.00–1.04]

0.024*

1.02 [0.99–1.06]

0.187

1.03 [1.01–1.05]

0.009*

≥ 65

Weight (Kg)

Refd

Refd

BMI (kg/m2)
< 25 kg/m2

Refd
2

Refd

Refd

25 ≤ BMI < 30 kg/m

0.55 [0.44–0.71]

< 0.001*

0.80 [0.49–1.30]

0.368

0.49 [0.38–0.64]

< 0.001*

0.73 [0.48–1.10]

0.134

0.93 [0.42–2.11]

0.875

0.63 [0.40–1.00]

< 0.050*

Waist circumference (Cm)

1.01 [1.00–1.02]

< 0.001*

1.01 [1.00–1.02]

0.012*

1.01 [1.00–1.02]

0.001*

≥ 30 kg/m2

Smoking history (%)
Never smoked

Refd

Refd

Refd

Ex-smoker

1.04 [0.83–1.30]

0.753

1.35 [0.86–2.14]

0.189

1.09 [0.85–1.39]

0.493

Current smoker

5.06 [4.05–6.31]

< 0.001*

5.71 [3.68–8.86]

< 0.001*

5.7X [4.50–7.25]

< 0.001*

Alcohol history (%)
Never

Refd

Refd

Refd

0–5 years

2.48 [1.85–3.32]

< 0.001*

2.50 [1.37–4.56]

0.003*

2.48 [1.80–3.51]

< 0.001*

6–10 years

2.76 [1.85–3.32]

< 0.001*

3.38 [1.72–6.28]

< 0.001*

2.73 [1.90–3.94]

< 0.001*

11–15 years

2.79 [1.92–4.06]

< 0.001*

3.21 [1.55–6.61]

0.002*

3.04 [2.03–4.54]

< 0.001*

> 15 years

1.97 [1.57–2.48]

< 0.001*

1.52 [0.93–2.47]

0.092*

2.11 [1.64–2.71]

< 0.001*

Fasting blood glucose (mg/dL)

1.00 [1.00–1.01]

0.034*

1.01 [1.00–1.02]

0.007

1.00 [1.00–1.01]

0.055

Elevated blood glucose (%)b

0.91 [0.73–1.14]

0.426

0.16 [0.08–0.33]

< 0.001

1.15 [0.91–1.46]

0.235

a
b
c
d

Elevated Blood pressure was defined as a systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg
Comparison by unpaired t-test or χ2 versus Normal BP

Elevated blood glucose ≥ 100 mg/dL after minimum 6-h fast
Ref: reference category

Table shows results from the multivariate analysis assessing independent participants’ characteristics associated to the elevated BP, comparison between each time
the normal BP group versus elevated BP, versus poorly controlled BP and versus new discovered cases BP groups

Sub-Sahara Africa [6, 22]. However, it is lower compared
to the pooled weighted awareness rate of 16.9% in 1990,
29.2% in 2000 and 33.7% in 2010 reported by Adeloye
et al. [23] from population-based studies on hypertension
in Africa. The availability of data on awareness rates of
hypertension in sub-Saharan Africa (SSA) in general, and
from rural areas in particular, are scattered and generated
by a wide range of studies differing in methodology thus
limiting the opportunity for reliable comparisons [7, 24,
25]. However, the recent study by Chow et al. [26] reports
that only one in three individual is aware of their hypertension status (i.e. higher than in our study), and about
only 8% have their blood pressure controlled (i.e. lower
than in our study). The poor treatment control in African
settings has been largely reported by other authors, however the 37.8% reported rate by this study is higher than
the reported average of 23.4% [26]. The high proportion

of rural dwellers with uncontrolled hypertension in our
study can be partially explained by geographically inaccessibility to health facilities for treatment monitoring.
High prevalence found in this study

This study identified an overall prevalence of Elevated
BP of 21.2% (95% CI = 20.0–22.4%). A prior populationbased study in Rwanda estimated the prevalence of HTN
in people between 15 and 64 years old at 15.3% (16.4% for
males and 14.4% for females) [22], indicating that ~ 1 million people are living with HTN in Rwanda. The reported
rate of elevated BP in this study was also lower than the
27.7% reported by a workplace-screening program conducted in an urban Ethiopian setting [27]. Other studies
from rural areas of Sub-Saharan Africa have reported variable rates of HTN prevalence that ranges from 5 to 52%
[8, 28, 29]. Adeloye et al. [23] had estimated hypertension
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pooled prevalence pooled in Africa at 26.1% (95% CI:
23.6–33.6). In line with those other pooled data, the
results presented in the current study confirm a serious
concern of the rising prevalence of hypertension in rural
Rwanda. This threat is further exacerbated by an underresourced healthcare system; the nationwide network of
healthcare clinics available to treat NCDs in Rwanda only
serve approximately 80,000 patients, representing a coverage of < 10% [30]. These data indicate that the majority
of Rwandan adults with HTN are not only untreated, but
undiagnosed.
Participants’ characteristics in this study

The participant characteristics associated with elevated
BP in this study are similar to the preliminary data
reported by Muggli et al. [28] from another screening
event held in the rural area of the District of Nyaruguru
(Southern Rwanda) which found a much low prevalence
of hypertension at 8.8%. However, that screening event
reported a median age of 32 years, much younger than
46 ± 16 years reported in this study. This lower age likely
contributes to the low prevalence of hypertension found
in their report. As reported in other studies [7, 10, 17,
29], gender was not significantly associated to elevated
BP in our study. However, consistent with other studies
[25, 31, 32], advancing age was a significant predictor of
elevated BP in this study.
The association between overweight and elevated
blood pressure has been long-established, including in
African populations [15, 33–35]. This study revealed a
high prevalence of overweight and obesity as noted in
other prior studies conducted in rural Rwandan areas
[22]. The relationship between BP and anthropometric
indices such as BMI, WC, waist to hip ratio (WHpR), and
waist to height ratio (WHtR) have been described in others studies [33]. Our study was not powered to assess this
comparison between overweight indices, and some indices were not available for analysis. Therefore, we added
all raw data on weight, height, BMI and WC into analysis
both univariate and multivariate after assess collinearity
with correlation matrix between variables. As the distribution of BP category was similar across BMI categories,
it was not conclusive to clearly draw a conclusion on the
association between the BMI categories and the elevated
BP in our study. This was probably due to the small sample size in cells.
Nevertheless, this finding is unexpected and further
work is needed to validate the association identified in
this study since these are in contrast with other reports
from rural India [34] and Nigerian [35] which identify a
higher BMI as a major risk factor for hypertension [18,
36, 37].
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Other risk factors identified in multivariable analysis
as independently associated to elevated BP are in line
with previous Rwanda WHO STEPs study by Nahimana
et al. [22]. In their nationwide study, a logistic regression
model revealed that age, alcohol consumption, blood glucose levels, and raised BMI were significantly associated
with hypertension, a finding confirmed in this study.
Implication for strategy for the prevention, diagnosis
and treatment of hypertension in Rwanda

This study brings additional evidence to support tailored measures for the prevention, diagnosis and treatment of hypertension in rural populations in Rwanda.
Recent reviews analyzing root causes for poor blood
pressure control in Rwanda [38] and in Eastern SubSaharan Africa [39] highlight this unmet healthcare
need. On a global scale, the World Health Organization
(WHO) has created a target to reduce heart attacks and
stroke by 25% by 2025 [17], and the World Heart Federation (WHF) launched a roadmap focusing on raised BP
awareness, treatment, and control during the 2015 World
Health Assembly in Geneva [40]. Monitoring through
systematically organized periodic screening campaigns
for HTN, diabetes, and other NCD risk factors in rural
population remains a key strategy for optimizing treatment and control [24]. Early detection with opportunistic
screening campaigns can also mitigate multiple barriers
like poor health education literacy [38] and low socioeconomic status [39]. However, given the need to balance
competing healthcare priorities including infectious diseases, nutritional deficiencies, and maternal and perinatal morbidity and mortality, a reallocation of healthcare
resources towards continuous monitoring of NCDs in
LMICs is necessary [6].
Study limitations

This study fills in a scientific data gap and its large sample
size is adequate for subgroup comparisons. This is also
one of the first studies to characterize the blood pressure and blood glucose profiles in a remote rural area
in Rwanda through a community screening. However, it
has also some limitations. First, given the current study
is not a systematic population-based screening, bias from
participant self-selection likely influenced the results of
this study. Second, given the cross-sectional design of
this screening study, we are unable to determine temporality and causality in the study; therefore, causation can
only be inferred. Third, like other opportunistic screening studies wherein the BP measurement are taken at a
single visit, this is indeed a limitation. However, the BP
measurements were taken through a rigorous and standardized protocol (3 times, with 1-min intervals, after rest
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period). Additionally, all subjects with elevated BP were
referred to nearest health facilities -as usual procedure,
where hypertension diagnosis was confirmed for all the
detected elevated BP cases, and followed an appropriate management. The follow up data are not part of this
manuscript. The study reports only elevated BP and not
prevalence of hypertension because the three blood pressure measurements were performed only on one occasion. Fourth, we were unable to explore the contribution
of other risk factors such as unhealthy diet, salt intake,
physical activity and psychosocial stress, the lack of
information on those risk factors that significantly affects
the prevalence of hypertension and limits the strength of
the conclusions. Such parameters were not easy to legitimate and scientifically evaluate through an opportunistic screening campaign, so the related information were
not available during casual data collection.” Additionally,
the quantification of alcohol intake and smoking where
rather empirical in the region where traditional alcoholic
drinks [41] and traditional pipe smoking were hard to
define according to international standards [42]. There
might be also social desirability biases to underestimating some of the lifestyle and behavioral questions, such
as smoking and alcohol consumptions. Despite these
limitations, the study makes significant contribution and
fills a substantial gap in the current Rwanda and regional
context. The use of standardized and robust methodologies, tools and high response rate observed in the study
increased its representativeness and strengthens its value
in informing the CVDs prevention by enabling tailored
preventive measures and optimize the treatment control.

Conclusion
This opportunistic screening findings confirm a high rate
of newly discovered elevated BP and poor control among
rural population in Rwanda. This study identified age,
current smoking, and alcohol history and waist circumference to be the risks associated with elevated BP. Having such high rate of newly discovered abnormal BP from
that rural population would imply an epidemiological
risk profile transition for hypertension, that needs further studies. Nevertheless, these data support the need
to strengthen also in rural areas of Rwanda an adequate
strategy for the prevention, early diagnosis and treatment
of hypertension. Future longitudinal studies to analyse in
more details the specific CVDs risk in that population are
needed.
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